FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical industry and represents a glucosamine or its salts prolonged release dosage form containing a combination of hydroxypropyl methylcellulose of molecular weight 100,000 and hydroxypropyl methylcellulose of molecular weight 200,000 as a delayed release agent, and one or more pharmaceutically acceptable excipients, wherein glucosamine and its salts are found partially in an intragranular form and partially in an extragranular form.
EFFECT: invention provides the glucosamine release in an amount and at a rate sufficient to maintain an effective level of blood serum glucosamine.
4 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITIONS OF ACOTIAMIDE AND PROTON PUMP INHIBITOR | 2019 |
|
RU2820820C2 |
| PHARMACEUTICAL ANTI-DIABETIC COMPOSITION OF PROLONGED ACTION | 2011 |
|
RU2465896C2 |
| ANTI-TUBERCULOSIS STABLE PHARMACEUTICAL COMPOSITION IN A FORM OF A COATED TABLET COMPRISING GRANULES OF ISONIAZID AND GRANULES OF RIFAPENTINE AND ITS PROCESS OF PREPARATION | 2014 |
|
RU2682178C2 |
| ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2593939C2 |
| PHARMACEUTICAL COMPOSITION AT DELAYED RELEASE OF PHARMACEUTICALLY ACTIVE SUBSTANCE AND METHOD FOR RELEASING PHARMACEUTICALLY ACTIVE SUBSTANCE | 1999 |
|
RU2259826C2 |
| ANTIEMETIC EXTENDED RELEASE SOLID DOSAGE FORMS | 2014 |
|
RU2679448C2 |
| PHARMACEUTICAL DRUG FORM FOR PERORAL INTRODUCTION TO REDUCE INTER-INDIVIDUAL VARIABILITY, IN PARACETAMOL-CONTAINING COMPOSITIONS IN PATIENT | 2009 |
|
RU2517139C2 |
| METHOD OF PRODUCING AN ANTIOXIDANT AGENT IN THE FORM OF A TABLET WITH PROLONGED EFFECT | 2019 |
|
RU2712445C1 |
| ANTISENSE COMPOSITIONS AND METHODS FOR PRODUCTION AND USE THEREOF | 2009 |
|
RU2739302C2 |
| PHARMACEUTICAL COMBINATION, COMPOSITION, AND COMBINED COMPOSITION, CONTAINING GLUCOKINASE ACTIVATOR AND PPAR RECEPTOR ACTIVATOR, AND THEIR PREPARATION METHOD, AND THEIR USE | 2019 |
|
RU2781638C2 |
